[1] REYA T, MORRISON S J, CLARKE M F, et al. Stem cells, cancer, and cancer stem cells［J］.Nature, 2001, 414(6859):105-111.

[2] BEACHY P A, KARHADKAR S S, BERMAN D M. Tissue repair and stein cell renewal in carcinogenesie［J］.Nature, 2004, 432(7015):324-331.

[3] CAI C, ZHU X. The Wntβ-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer［J］.Mol Med Rep, 2012, 5(5):1191-1196.

[4] MOITRA K, LOU H, DEAN M. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development［J］.Clin Pharmacol Ther, 2011, 89(4):491-502.

[5] LI L, COLE J, MAGOLIN D A, et al. Cancer stem cell and stromal microenvironment［J］. Ochsner J, 2013, 13(1):109-118.

[6] GINESTIER C, HUR M H, CHARAFE-JAUFFRET E, et al.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome［J］.Cell Stem Cell, 2007, 1(5):555-567.

[7] ROUNTREE C B, SENADHEERA S, MATO J M, et al. Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice［J］. Hepatology, 2008, 47(4):1288-1297.

[8] SINGH S K, HAWKINS C, CLARKE I D, et al. Identification of human brain tumour initiating cells［J］.Nature, 2004, 432(7015):396-401.

[9] ERAMO A, LOTTI F, SETTE G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population［J］.Cell Death Differ, 2008, 15(3):504-514.

[10] YEUNG T M, GANDHI S C, WILDING J L, et al. Cancer stem cells from colorectal cancer-derived cell lines［J］.Proc Natl Acad Sci USA, 2010, 107(8):3722-3727.

[11] LI C, HEIDT D G, DALERBA P, et al. Identification of pancreatic cancer stem cells［J］.Cancer Res, 2007, 67(3):1030-1037.

[12] TOKAR E J, DIWAN B A, WAALKES M P, et al. Arsenic exposure transforms human epithelial stemprogenitor cells into a cancer stem-like phenotype［J］.Environ Health Perpect, 2010, 118(1):108-115.

[13] KIESSLICH T, BERR F, ALINGER B, et al. Current status of therapeutic targeting of developmental signalling pathways in oncology［J］.Curr Pharm Biotechnol, 2012, 13(11):2184-2220.

[14] ROY M, PEAR W S, ASTER J C. The multifaceted role of Notch in cancer［J］.Curr Opin Genet Dev, 2007, 17(1):52-59.

[15] DICKSON B C, MULLIGAN A M, ZHANG H, et al. High-level JAG1 mRNA and protein predict poor outcome in breast cancer［J］.Mod Pathol, 2007, 20(6):685-693.

[16] CURTIN J C, LORENZI M V. Drug discovery approaches to target Wnt signaling in cancer stem cells［J］.Oncotarget, 2010, 1(7):552-566.

[17] VERMEULEN L, D E SOUSA E MELO F, VAN DER HEIJDEN M, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment［J］.Nat Cell Biol, 2010, 12(5):468-476.

[18] NOGUERA-TROISE I, DALY C, PAPADOPOULOS N J, et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis［J］.Nature, 2006, 444(7122):1032-1037.

[19] LI K, LI Y, WU W, et al. Modulation of notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3［J］.J Biol Chem, 2008, 283(12):8046-8054.

[20] PRINCE M E, SIVANANDAN R, KACZOROWSKI A.et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma［J］.Proc Natl Acad Sci USA, 2007, 104(3):973-978.

[21] BARGINEAR M F, LEUNG M, BUDMAN D R, et al. The hedgehog pathway as a therapeutic target for treatment of breast cancer［J］.Breast Cancer Res Treat, 2009, 116(2):239-246.

[22] HE B, REGUART N, YOU L, et al. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations［J］.Oncogene, 2005, 24(18):3054-3058.

[23] FUJII N, YOU L, XU Z, et al. An antagonist of disheveled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth［J］.Cancer Res, 2007, 67(2):573-579.

[24] ARBER N, EAGLE C J, SPICAK J.et al. Celecoxib for the prevention of colorectal adenomatous polyps［J］.N Engl J Med, 2006, 355(9):885-895.

[25] TAKEBE N, WARREN R Q, IVY S P, et al. Breast cancer growth and metastasis: interplay between cancer stem cells,embryonic signaling pathways and epithelial-to-mesenchymal transition［J］.Breast Cancer Res, 2011, 13(3):211.

[26] 文宇, 熊力, 裴冬妮, 等.纳米光敏剂的研究进展［J］.中国现代医学杂志, 2013, 23(23):52-61.

    WEN Yu, XIONG Li, PEI Dongni, et al. Research progress of Nano-Photosensitizers［J］. China Journal of Modern Medicine,2013,23(23):52-61.

[27] YU C H, YU C C. Photodynamic therapy with 5-Aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells［J］.PLoS One, 2014, 9(1):e87129.doi:10.1371/journal.pone.0087129.

[28] BIGARELLA C L, LIANG R, GHAFFARI S, et al. Stem cells and the impact of ROS signaling［J］.Development, 2014, 141(22):4206-4218.

[29] ISHIMOTO T, NAGANO O, YAE T, et al.CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth［J］.Cancer Cell, 2011, 19(3):387-400.

[30] WEYERGANG A, SELBO P K, BERSTAD M E, et al. Photochemical internalization of tumor-targeted protein toxins［J］.Lasers Surg Med, 2011, 43(7):721-733.

[31] BOSTAD M, KAUSBERG M, WEYERGANG A, et al. Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization［J］.Mol Pharm, 2014, 11(8):2764-2776.

[32] STRATFORD E W, BOSTAD M, CASTRO R, et al. Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity［J］.Biochim Biophys Acta, 2013, 1830(8):4235-4243.

[33] VISVADER J E, LINDEMAN G J. Cancer stem cells:current status and evolving complexities［J］.Cell Stem Cell, 2012, 10(6):717-728.

[34] LAI C W, WANG YH, LAI C H. et al. Iridium-complex-functionalized Fe3O4/Sio2 coreshell nanoparticles:a facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy［J］.Small, 2008, 4(2):218-224.

[35] JANG B, CHOI Y. Photosensitizer-conjugated gold nanorods for enzyme activatable fluorescence imaging and photodynamic therapy［J］.Theranostics, 2012, 2(2):190-197.

[36] TIAN G, REN W, YAN L, LIANG YAN, et al. Red-emitting upconverting nanoparticles for photodynamic therapy in cancer cells under near-infrared excitation［J］.Small, 2013, 9(11):1929-1938.

[37] FRANCESCA M, DIETRICH S, ELENA R, et al. Folate-targeted PEGylated liposomes improve the selectivity of PDT with metatetra(hydroxyphenyl)-chlorin (m-THPC)［J］.Photochem Photobiol Sci, 2013, 12(5):823-834.

[38] ABLIZ E, COLLINS J E, BELL H, et al. Novel applications of diagnostic X-rays in activating a clinical photodynamic drug: Photofrin II through X-ray induced visible luminescence from “rare-earth” formulated particles［J］.Journal of X-Ray Science and Technology, 2011, 19(4):521-530.

[39] STARKEY J R, PASCUCCI E M, DROBIZHEV M A, et al. Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment［J］.Biochim Biophys Acta, 2013, 1830(10):4594-4603.

[40] 李红蕊,丁 倩,陈枢青,等.针对肿瘤干细胞的抗体靶向治疗—靶向部分信号通路及细胞表面标志分子［J］.中国细胞生物学学报, 2015, 37(1):115-123.

    LI Hongrui, DING Qian, CHEN Shuqing, et al. Antibody therapeutics that target cancer stem cells(cscs)-for some signal pathways and cscs markers［J］.Chinese Journal of Cell Biology, 2015, 37(1):115-123.